Last reviewed · How we verify
Minocycline vs Lymecycline
Minocycline vs Lymecycline is a Tetracycline antibiotic Small molecule drug developed by Darier. It is currently FDA-approved for Acne vulgaris, Rosacea, Bacterial infections (skin and soft tissue).
Both minocycline and lymecycline are tetracycline antibiotics that inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit.
Both minocycline and lymecycline are tetracycline antibiotics that inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit. Used for Acne vulgaris, Rosacea, Bacterial infections (respiratory, urinary, skin).
At a glance
| Generic name | Minocycline vs Lymecycline |
|---|---|
| Sponsor | Darier |
| Drug class | Tetracycline antibiotic |
| Target | Bacterial 30S ribosomal subunit |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
These tetracyclines prevent bacterial protein synthesis by blocking the attachment of aminoacyl-tRNA to the ribosome. Lymecycline is a derivative of tetracycline with improved oral bioavailability and tissue penetration compared to minocycline. Both agents are used in dermatology for their anti-inflammatory properties in addition to their antimicrobial effects.
Approved indications
- Acne vulgaris
- Rosacea
- Bacterial infections (skin and soft tissue)
Common side effects
- Photosensitivity
- Nausea and gastrointestinal upset
- Vaginal candidiasis
- Dizziness or vertigo (minocycline)
- Esophageal irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Minocycline vs Lymecycline CI brief — competitive landscape report
- Minocycline vs Lymecycline updates RSS · CI watch RSS
- Darier portfolio CI
Frequently asked questions about Minocycline vs Lymecycline
What is Minocycline vs Lymecycline?
How does Minocycline vs Lymecycline work?
What is Minocycline vs Lymecycline used for?
Who makes Minocycline vs Lymecycline?
What drug class is Minocycline vs Lymecycline in?
What development phase is Minocycline vs Lymecycline in?
What are the side effects of Minocycline vs Lymecycline?
What does Minocycline vs Lymecycline target?
Related
- Drug class: All Tetracycline antibiotic drugs
- Target: All drugs targeting Bacterial 30S ribosomal subunit
- Manufacturer: Darier — full pipeline
- Therapeutic area: All drugs in Dermatology / Infectious Disease
- Indication: Drugs for Acne vulgaris
- Indication: Drugs for Rosacea
- Indication: Drugs for Bacterial infections (skin and soft tissue)
- Compare: Minocycline vs Lymecycline vs similar drugs
- Pricing: Minocycline vs Lymecycline cost, discount & access